Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Abolfazli R, Hosseini A, Gholami K, Javadi MR, Torkamandi H, Emami S
ISRN Neurol. 2012; 2012:786526. Epub 2012 Aug 09. PMID: 22928117.Abstract
